BioMed Research International

Autoimmune Rheumatic Diseases


Status
Published

1Center for Autoimmune Diseases Research (CREA), Universidad del Rosario, Carrera 24 No. 63C-69, 111221 Bogota, Colombia

2Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel

3Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany

4Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IFIMAV, Avenida de Valdecilla, s/n 39008, Santander, 39008 Cantabria, Spain


Autoimmune Rheumatic Diseases

Description

Autoimmune diseases (ADs) are chronic conditions initiated by the loss of immunological tolerance to self-antigens and are characterized by activation of T cells or B cells, or both, leading to pathology. ADs represent a heterogeneous group of disorders that affect specific target organs or multiple organ systems. The chronic nature of these diseases places a significant burden on the utilization of medical care, direct and indirect economic costs, and quality of life.

A number of patterns of illness affecting joints or muscles are associated with autoimmune and inflammatory responses and are, therefore, called autoimmune rheumatic diseases. They include rheumatoid arthritis, systemic lupus erythematosus, antiphospholipid syndrome, polymyalgia rheumatica, systemic sclerosis, Sjögren’s syndrome, polymyositis and dermatomyositis, vasculitis, Behcet´s disease, myasthenia gravis, sarcoidosis, and a spectrum of related syndromes. Rheumatological features also occur with nonrheumatic autoimmune diseases (e.g., autoimmune thyroid diseases).

We invite investigators to submit original research as well as review articles that will support and contribute to understand the clinical, laboratory, and demographic factors of autoimmune rheumatic diseases. Potential topics include, but are not limited to:

  • Rheumatoid arthritis
  • Systemic lupus erythematosus
  • Antiphospholipid syndrome
  • Polymyalgia rheumatica
  • Systemic sclerosis
  • Sjögren’s syndrome
  • Polymyositis and dermatomyositis
  • Vasculitis
  • Behcet´s disease
  • Autoimmune thyroid disease and autoimmune diseases
  • Cardiovascular disease in autoimmune diseases

Before submission authors should carefully read the journal’s Author Guidelines which are located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/bmri/rheumatology/ard/ according to the following schedule:

BioMed Research International
 Journal metrics
Acceptance rate31%
Submission to final decision67 days
Acceptance to publication30 days
CiteScore4.100
Journal Citation Indicator0.610
Impact Factor3.411
 Submit

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.